Compare Barclays PLC (BCS) vs Johnson & Johnson (JNJ) Price & Performance

Barclays PLCTrade

Johnson & JohnsonTrade

Price performance (Past 24H)

Key statistics

Barclays PLC vs Johnson & Johnson — how do they compare? Barclays PLC trades at $28 (market cap $93.87B), while Johnson & Johnson trades at $258.91 (market cap $626.09B). The key difference: Johnson & Johnson is far larger — about 6.7× Barclays PLC's market cap, and Barclays PLC pays the higher dividend (2.19%). Which is the better fit depends on your goals.

	BCS	JNJ
Market Cap	$93.87B	$626.09B
Sector	Financials	Health
52-Week High	$28.56	$267.24
52-Week Low	$19.36	$172.78
Dividend Yield	2.19%	2.06%
Volume	—	6,156,228
Enterprise Value	—	$654.37B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BCS

Barclays investors urged to join class action over alleged misleading info on mortgage exposure.GlobeNewsWire · 4 days agoBearish View details →

JNJ

Invesco's PEY ETF outperforms with a dividend-growth filter, offering higher returns and reliable income.24/7 Wall Street · 18 hours agoBullish Johnson & Johnson stock holds near 52-week high; growth strong but valuation pricey, patience advised.24/7 Wall Street · 21 hours agoNeutral Fidelity Dividend ETF's payout is safe but not ideal for steady income due to variable quarterly dividends.24/7 Wall Street · 22 hours agoNeutral View details →

About Barclays PLC

Barclays is a universal bank headquartered in the United Kingdom. It operates via two principal segments

About Johnson & Johnson

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.